Pamidronate treatment of steroid associated osteonecrosis in young patients treated for acute lymphoblastic leukaemia - Two-year outcomes

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue 2, 2006, Pages 161-167

  Nguyen, Thi Thuy An ^a   Zacharin, Margaret R ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

Avascular necrosis; Diphosphonate; Osteonecrosis; Pamidronate

Indexed keywords

CORTICOSTEROID; PAMIDRONIC ACID; STEROID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANALGESIA; ARTICLE; BONE DISEASE; BONE NECROSIS; BONE RADIOGRAPHY; CHILD CARE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE COURSE; DRUG INDICATION; DRUG MEGADOSE; FEMUR HEAD NECROSIS; HUMAN; INTERVENTION STUDY; LONG TERM CARE; MOBILIZATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PALLIATIVE THERAPY; PROPHYLAXIS; TOTAL HIP PROSTHESIS;

EID: 33644761773     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2006.19.2.161     Document Type: Article

References (24)

1. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002; 32: 94-124.
2. Nishikawa M, Akatsu T, Katayarna Y, Yasutomo Y, Kado S, Kugal N, Yamamoto M, Nagata N. Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures. Bone 1996; 18: 9-14.
3. Sahni M, Guenther HL, Fleisch H, Collin P, Martin TJ. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J Clin Invest 1993; 91: 2004-2011.
4. Little DG, Peat RA, McEvoy A, Williams PR, Smith EJ, Baldock PA. Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats. J Bone Miner Res 2003; 18: 2016-2033.
5. Astrand J, Aspenberg P. Systemic alendronate prevents resorption of necrotic bone during revascularization. A bone chamber study in rats. BMC Musculoskelet Disord 2002; 7: 3-19.
6. Hurel SJ, Kendall-Taylor P. Avascular necrosis secondary to postoperative steroid therapy. Br J Neurosurg 1997; 11: 356-358.
7. Gogas H, Fennelly D. Avascular necrosis following extensive chemotherapy and dexamethasone treatment in a patient with advanced ovarian cancer: case report and review of the literature. Gynecol Oncol 1996; 63: 379-381.
8. Steinberg ME, Hayken GD, Steinberg DR. A quantitative system for staging avascular necrosis. J Bone Joint Surg Br 1995; 77: 34-41.
9. Ito H, Matsuno T, Kaneda K. Prognosis of early stage avascular necrosis of the femoral head. Clin Orthop Relat Res 1999; (358): 149-57.
10. Merle D'Aubigne R, Postel M, Mazabraud A, Massias P, Gueguen J, France P. Idiopathic necrosis of the femoral head in adults. J Bone Joint Surg Br 1965; 47: 612-633.
11. Satku K, Kumar VP, Chong SM, Thambyah A. The natural history of spontaneous osteonecrosis of the medial tibial plateau. J Bone Joint Surg Br 2003; 85: 983-988.
12. Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head [see comment]. J Bone Joint Surg Am 1995; 77: 459-474.
13. Fleisch H. Bisphosphonates: mechanisms of action. Endocr Rev 1998; 19: 80-100.
14. Rogers MJ, Frith JC, Luckman SP, Coxon FP, Benford HL, Monkkonen J, Auriola S, Chilton KM, Russell RG. Molecular mechanisms of action of bisphosphonates. Bone 1999; 24 (Suppl 5): 73S-79S.
15. Shipman CM, Rogers MJ, Apperley JF, Russell RG, Croucher PI. Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity [see comment]. Br J Haematol 1997; 98: 665-672.
16. Glorieux FH. The use of bisphosphonates in children with osteogenesis imperfecta. J Pediatr Endocrinol Metab 2001; 14 (Suppl 6): 1491-1495.
17. Zacharin M, Kanumakala S. Pamidronate treatment of less severe forms of osteogenesis imperfecta in children. J Pediatr Endocrinol Metab 2004; 17: 1511-1517.
18. Astrom E, Soderhall S. Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta [see comment]. Arch Dis Child 2002; 86: 356-364.
19. Walls J, Bundred N, Howell A. Hypercalcemia and bone resorption in malignancy. Clin Orthop Relat Res 1995; (312): 51-63.
20. Little DG, Smith NC, Williams PR, Briody JN, Bilston LE, Smith EJ, Gardiner EM, Cowell CT. Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis. J Bone Miner Res 2003; 18: 1300-1307.
21. Little DG, McDonald M, Sharpe IT, Peat R, Williams P, McEvoy T. Zoledronic acid improves femoral head sphericity in a rat model of Perthe's disease. J Orthop Res 2005; 4: 862-868.
22. Kim, HK, Randall TS, Bian H, Jenkins J, Garces A, Bauss F. Ibandronate for prevention of femoral head deformity after ischemic necrosis of the capital femoral epiphysis in immature pigs. J Bone Joint Surg Am 2005; 87: 550-557.
23. Agarwala S, Jain D, Joshi VR, Sule A. Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective, open label study. Rheumatology (Oxf) 2005; 44: 352-359.
24. Little DG. Biphosphonates in Perthe's disease. In: Orthopaedic Conference, Cairns, 2004.